EU Opens Align Antitrust Probe
EU Commission Investigates Align Technology Over Alleged Tying of Invisalign and iTero Scanners
Key Points
On June 30, 2026, the European Commission announced an antitrust investigation into Align Technology to assess whether tying iTero intra-oral scanners to Invisalign clear aligners in the European Economic Area violates EU competition rules.
The probe was prompted by a complaint from a competitor, with the Commission examining whether Align’s practices breach EU competition rules.
Industry-insight outlet MLex explicitly describes the investigation as focusing on possible bundling (tying) of Align’s dental products, highlighting EU scrutiny of bundling in the dental devices sector.
The coverage of the EU probe across multiple outlets—including major outlets like WSJ and Marketscreener—signals broad media attention to EU enforcement actions in the dental-device market.
The European Commission opened a formal antitrust investigation into Align Technology on June 30, 2026, targeting the U.S. company behind Invisalign clear aligners and iTero intra-oral scanners. The Next Web reports the probe is examining whether Align illegally tied its iTero scanners to Invisalign orders — forcing dental professionals to buy one product to use the other — in a potential breach of EU competition rules.
The case marks a landmark moment: GuruFocus notes it is the first formal antitrust investigation into the medical devices sector in EU regulatory history. Align holds over 90% of the global clear aligner market and annual revenues of roughly $4.1 billion. EU Antitrust Commissioner Teresa Ribera said the inquiry "underscores our commitment to preserve fair markets that work for everyone, including in healthcare."
How Align Allegedly Locked Out Rival Scanner Makers
The core allegation is a "restrictive interoperability strategy." To make Invisalign aligners, a dentist must submit a precise 3D scan of a patient's teeth. The Next Web reports that Align allegedly refused to accept standard digital files from rival scanner brands, such as 3Shape or Medit. That refusal effectively forced clinics to buy an iTero scanner — which costs thousands of dollars — just to place Invisalign orders.
The Commission's press release states that Align "effectively forced dental professionals to purchase the iTero scanner if they wish to order Invisalign for their patients." The probe was triggered by a complaint from an unnamed competitor. Industry analysts point toward rivals like Straumann Group or Envista, both of which have expanded their own scanner and aligner partnerships in recent years, according to GuruFocus.
Align's Patent Cliff Created the Opening for This Probe
Align held near-total dominance over clear aligners for nearly two decades, protected by extensive patents. When key Invisalign patents began expiring in 2017, rivals finally had room to enter the market. The Commission alleges that Align responded by tightening its digital ecosystem — restricting which scanners could submit automated Invisalign orders — to defend its market position as patent protection faded.
Marketscreener reports the EU is scrutinizing whether those post-2017 moves amount to an abuse of dominance under Article 102 of the EU treaty. If found guilty, Align faces fines of up to 10% of its total global annual turnover. That would equal roughly $410 million based on current revenues. The Commission could also order Align to open its platform to scans from any compatible third-party device.
Stock Drops 4% as Analysts Warn of a Long Review Ahead
Markets reacted quickly. Align Technology shares fell $6.21 to $167.22 — a drop of about 4% — in intraday trading on June 30, according to GuruFocus. A formal probe is not a finding of guilt, but the extended review process allows regulators to dig deep into pricing, contracts, and competitive effects. That uncertainty can weigh on a stock for months or even years.
Investment bank Leerink maintained an Outperform rating on ALGN with a price target of $230, signaling confidence that Align can weather the probe. Still, GuruFocus notes the duration between investigation and final ruling in EU antitrust cases is often measured in years, not months. Align has not issued a formal rebuttal, but CEO Joe Hogan has previously described the iTero-to-Invisalign workflow as a "seamless, integrated benefit for doctors."
What the Case Could Mean for European Dental Patients
If the EU forces Align to accept scans from any high-quality scanner, competition in both markets could intensify sharply. More scanner brands competing for dental clinics could push prices down. More aligner makers gaining fair access could lower the cost of clear aligner treatment for millions of Europeans. More than 22 million patients worldwide have already been treated with Invisalign, according to Yahoo Finance.
The case also signals that the EU's "gatekeeper" scrutiny — long focused on Big Tech — is now moving into high-tech healthcare. This probe mirrors landmark EU cases against Microsoft and Google, where dominant firms were accused of tying secondary products to their core platforms. Marketscreener notes the investigation underscores growing EU concern about anti-competitive bundling across the entire dental device sector.
Sentiment
Mostly NegativePublishers
13
Articles
77
Reach
90
